Dasatinib-Induced CMV Hepatitis in an Immunocompetent Patient: A Rare Complication of a Common Drug()

Dasatinib is a common anticancer drug used in the treatment of leukemia. Several side effects have been reported, the most common being myelosuppression, diarrhea, edema, and nausea. Three papers have been published reporting hepatic side effects of dasatinib treatment. A rare side effect of dasatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Davalos, Fidencio, Chaucer, Benjamin, Zafar, Wahib, Salman, Shamim, Nfonoyim, Jay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Short communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907970/
https://www.ncbi.nlm.nih.gov/pubmed/27267844
http://dx.doi.org/10.1016/j.tranon.2015.12.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907970/
https://www.ncbi.nlm.nih.gov/pubmed/27267844
http://dx.doi.org/10.1016/j.tranon.2015.12.004

Ejemplares similares